DC-Chol hydrochloride NEW
| Price | $30 | $47 | $89 |
| Package | 10mg | 25mg | 50mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: DC-Chol hydrochloride | CAS No.: 166023-21-8 |
| Purity: 98.00% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | DC-Chol hydrochloride |
| Description | DC-Chol hydrochloride(DC-Cholesterol hydrochloride) inhibited the formation of Aβ40 fibrils under appropriate experimental conditions and significantly inhibited amyloid formation from oxidized hCT in a dose-dependent manner.DC-Chol hydrochloride induces an improved and balanced immunity, which could contribute to hepatitis B vaccine research. |
| Storage | Keep away from direct sunlight,Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 4.7 mg/mL (8.75 mM), Sonication is recommended. 10% DMSO+90% Saline : 0.47 mg/mL (0.87 mM), Solution. Methanol : 10 mg/mL (18.61 mM), Sonication is recommended. Ethanol : 20 mg/mL (37.23 mM), Sonication is recommended. |
| Keywords | βAmyloid | β Amyloid | DC-Chol Hydrochloride | DC-Chol | Cholesteryl 3β-N-(dimethylaminoethyl)carbamate | Cholesteryl 3b-N-(dimethylaminoethyl)carbamate | Cholesteryl 3beta-N-(dimethylaminoethyl)carbamate | BetaAmyloid | Beta Amyloid | bAmyloid | b Amyloid | Aβ40 | ?Cholesteryl 3β-N-(dimethylaminoethyl)carbamate hydrochloride |
| Inhibitors Related | Kaolin | Fluorene | Undecane | Ethyl palmitate | Rhamnose monohydrate | D(+)-Raffinose pentahydrate | HEPPS | Hydroxypropyl Cellulose | 1,8-Cineole | Tributyrin | Gluconate Calcium | Magnesium sulfate |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Immunology/Inflammation Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Bioactive Lipid Compound Library | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:191173-82-7
-
-
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1980.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-05-21 | |
| $1980.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-04-20 | |
|
VIP2Y
|
Shenzhen Nexcon Pharmatechs Ltd.
|
2026-03-30 | ||
|
VIP6Y
|
XIAMEN SINOPEG BIOTECH CO., LTD.
|
2026-02-05 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY